IMMUNE ADAPT, 1oz

"One of the common side effects of Western cancer treatments is a reduction of white blood cells. This makes the body more susceptible to longer recovery times from the treatment and increases the chance of opportunistic infection. If white blood cell counts are too low, chemotherapy treatments must be suspended until the levels rise again, thus prolonging the treatment cycle. Clinical trials have shown that the herbs in Immune Adapt Compound, taken concurrently with chemotherapy, stabilize white blood cell counts and reduce gastrointestinal and general toxicity symptoms. Codonopsis positively affects lymphocyte proliferation and interleukin-2 (IL-2) response rate and protects against the immunoglobulin M (IgM) suppressing effects of radiation therapy. Many chemotherapeutic agents can cause kidney damage. Astragalus, Atractylodes, Codonopsis and licorice have been shown to lower (BUN) and creatinine (Cr) levels, thus lowering the incidence of drug-induced nephrotoxicty. Reishi mushroom induces apoptosis, inhibits cell proliferation and suppresses cell migration of prostrate cancer cells by modulating MAPK and Akt cellular signaling and inhibiting transcription factors, thus inhibiting some of the early stage events in angiogenesis. Reishi has also been shown to inhibit both estrogen-dependent and estrogen-independent breast cancers by modulating estrogen receptors and NF-kappaB signaling. Eleuthero inhibits the cyclooygenase (COX) enzyme and lipid peroxidation, both of which are elevated in inflamed and cancerous cells. It selectively inhibits the COX-2 enzyme, which is partially responsible for the pain and swelling experienced with arthritis and inflammatory auto-immune conditions." - Winston: Herbal Therapeutics*